BOSCIA, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 10.660
AS - Asia 5.025
EU - Europa 4.593
SA - Sud America 1.645
Continente sconosciuto - Info sul continente non disponibili 671
AF - Africa 206
OC - Oceania 9
Totale 22.809
Nazione #
US - Stati Uniti d'America 10.412
SG - Singapore 2.082
IT - Italia 1.578
BR - Brasile 1.293
CN - Cina 878
DE - Germania 719
HK - Hong Kong 681
RU - Federazione Russa 576
VN - Vietnam 460
FR - Francia 381
SE - Svezia 369
GB - Regno Unito 278
FI - Finlandia 273
IN - India 176
BD - Bangladesh 154
AR - Argentina 103
UA - Ucraina 103
CA - Canada 96
ID - Indonesia 92
IQ - Iraq 78
MX - Messico 72
ZA - Sudafrica 65
TR - Turchia 64
NL - Olanda 62
CO - Colombia 57
PL - Polonia 55
VE - Venezuela 50
EC - Ecuador 49
PK - Pakistan 49
SA - Arabia Saudita 44
UZ - Uzbekistan 39
BE - Belgio 35
JP - Giappone 35
CZ - Repubblica Ceca 29
PH - Filippine 29
ES - Italia 28
MA - Marocco 27
CL - Cile 23
AT - Austria 22
LT - Lituania 22
UY - Uruguay 22
TN - Tunisia 21
AE - Emirati Arabi Uniti 20
CR - Costa Rica 18
KE - Kenya 18
PY - Paraguay 18
IL - Israele 17
JM - Giamaica 15
JO - Giordania 15
PE - Perù 15
BO - Bolivia 13
CI - Costa d'Avorio 13
IE - Irlanda 13
NP - Nepal 13
EG - Egitto 12
MY - Malesia 12
AZ - Azerbaigian 11
KZ - Kazakistan 9
CH - Svizzera 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
HN - Honduras 8
AL - Albania 7
DZ - Algeria 7
PA - Panama 7
PS - Palestinian Territory 7
AU - Australia 6
GE - Georgia 6
KG - Kirghizistan 6
LB - Libano 6
NI - Nicaragua 6
OM - Oman 6
GT - Guatemala 5
KH - Cambogia 5
NG - Nigeria 5
PT - Portogallo 5
SC - Seychelles 5
SN - Senegal 5
BG - Bulgaria 4
GR - Grecia 4
KR - Corea 4
RO - Romania 4
RS - Serbia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AM - Armenia 3
AO - Angola 3
EU - Europa 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
BN - Brunei Darussalam 2
BS - Bahamas 2
BW - Botswana 2
CG - Congo 2
DK - Danimarca 2
GA - Gabon 2
HU - Ungheria 2
LK - Sri Lanka 2
LY - Libia 2
Totale 22.104
Città #
Ashburn 1.143
Singapore 1.121
Dallas 848
Fairfield 748
San Jose 735
Hong Kong 662
Chandler 643
Milan 471
Woodbridge 468
Council Bluffs 342
Houston 326
Cambridge 301
Beijing 289
Seattle 287
Nyköping 285
Wilmington 262
Ann Arbor 258
New York 235
Lauterbourg 210
Jacksonville 198
Helsinki 194
Los Angeles 188
Rome 181
Lawrence 175
Roxbury 165
Ho Chi Minh City 139
Des Moines 113
Buffalo 109
Santa Clara 103
Hanoi 101
São Paulo 100
Elk Grove Village 98
Boardman 85
Munich 85
Brooklyn 75
Columbus 75
Bari 71
Falkenstein 71
San Diego 56
Paris 55
Nanjing 54
Jakarta 52
Chicago 48
Inglewood 48
Rio de Janeiro 47
Warsaw 45
London 44
Frankfurt am Main 41
Dong Ket 40
Princeton 39
Johannesburg 36
Tashkent 35
Turin 35
Belo Horizonte 34
Figino 34
Orem 34
Brussels 33
Tokyo 32
Montreal 31
Atlanta 30
Brasília 30
Denver 30
Naples 29
Amsterdam 28
Chennai 27
Mexico City 27
Phoenix 25
Baghdad 24
Toronto 24
Dhaka 23
Haiphong 23
Nuremberg 23
Brno 22
New Delhi 21
Hải Dương 20
San Francisco 20
Stockholm 20
Taranto 20
Porto Alegre 19
Palermo 18
Shanghai 18
Campinas 17
Curitiba 17
Espoo 17
Guangzhou 17
Montevideo 17
Noicattaro 17
Shenzhen 17
The Dalles 17
Turku 17
Washington 17
Ankara 16
Bologna 16
Da Nang 16
Goiânia 16
Guayaquil 16
Istanbul 16
Manchester 16
Moscow 16
San José 16
Totale 13.668
Nome #
Olio di silicone pesante vs olio di silicone e bottone sclerale nel distacco di retina complicato da PVR e rotture inferiori 396
Ciliochoroidal effusion syndrome associated with mebendazole systemic treatment 359
Liver fibrosis and retinal features in an older Mediterranean population: Results from the Salus in Apulia study 298
Subconjunctival sustained-release dexamethasone implant as an adjunct to trabeculectomy for primary open angle glaucoma 228
Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration 224
Correlation between retinal vessel rarefaction and psychometric measures in an older Southern Italian population 222
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 200
Cauterization of Ozurdex wound for the prevention of scleral leakage in vitrectomized eyes 200
Accuracy of Orbscan optical pachymetry in corneas with haze 196
One-year outcomes of 27-gauge versus 25-gauge pars plana vitrectomy for uncomplicated rhegmatogenous retinal detachment repair 190
Capsular block syndrome after implantation of an accommodating intraocular lens 189
In vivo evidence of epiretinal membrane formation secondary to acute macular microhole after posterior vitreous detachment 186
Inverted internal limiting membrane-flap technique for large macular hole: a microperimetric study 186
OCT Angiography in Acute Posterior Multifocal Placoid Pigment Epitheliopathy 184
Anterior capsule staining using micronized triamcinolone in the absence of red reflex 183
SD-OCT AND MICROPERIMETRIC CORRELATED CHANGES IN PROGRESSIVE X-LINKED RETINOSCHISIS AFTER VITRECTOMY: A CASE REPORT. 182
Study of macular and optic disk blood flow by angio‐OCT in Glucose‐6‐Phosphate Dehydrogenase (G6PD) deficient men and age‐related G6PD‐normal subjects 180
Morphologic and functional outcomes of different optical coherence tomography patterns of myopic foveoschisis after vitrectomy and inner limiting membrane peeling 178
Fundus autofluorescence and multiple evanescent white dot syndrome 177
Complete blood cell count indexes in non‐arteritic anterior ischemic optic neuropathy 174
Excimer Laser-Assisted Lamellar Keratoplasty and the Corneal Endothelium 172
Inverted internal limiting membrane-flap technique to treat a full-thickness macular hole complicating idiopathic macular telangiectasia type 2 167
Retinal Vascular Density on Optical Coherence Tomography Angiography and Age-related Central and Peripheral Hearing Loss in a Southern Italian Older Population 162
Diathermy of leaking sclerotomies after 23-gauge transconjunctival pars plana vitrectomy: a prospective study. 159
Choroidal neovascularization secondary to vitrectomy for idiopathic epiretinal membrane: report of an unusual case 158
Femtosecond laser assisted cataract surgery combined with intravitreal dexamethasone implant in patients with cataract and diabetic macular edema 158
Evaluation of corneal damage by combined Phacoemulsification and passive efflux of silicone oil in Vitrectomized eyes 157
GENTAMICIN-INDUCED MACULAR INFARCTION IN TRANSCONJUNCTIVAL SUTURELESS 25-GAUGE VITRECTOMY 149
Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema 149
Implementation of Lean healthcare methodology in designing an Intravitreal Injection Center: first Italian experience 147
Combined Radial Optic Neurotomy, Internal Limiting Membrane peeling, and Intravitreal Triamcinolone Acetonide for central Retinal Vein Occlusion 146
Topical betamethasone sodium phosphate, tetracycline hydrochloride and nonsteroidal anti-inflammatory drugs in the treatment of diabetic macular edema: a case report 146
Cauterization for the prevention of leaking sclerotomies after 23-gauge transconjunctival pars plana vitrectomy: an easy way to obtain sclerotomy closure. 145
Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. 144
Cost-effectiveness of intravitreal therapy with both anti-VEGF and Dexamethasone implant in patients with Diabetic Macular Edema 144
Combined topical anesthesia and sedation for open-globe injuries in selected patients 141
Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema: functional and anatomic results 140
INTRAVITREAL DEXAMETHASONE IMPLANT FOR REFRACTORY MACULAR EDEMA SECONDARY TO VITRECTOMY FOR MACULAR PUCKER. 139
Effects of single and multiple intravitreal injections of bevacizumab on neuronal viability of retinal ganglion cells in rats 138
Intravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsification 137
Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study 137
Corneal Interactive Programmed Topographic Ablation customized photoastigmatic keratectomy for correction of post keratoplasty astigmatism 136
DIABETIC MACULAR EDEMA AND CATARACT SURGERY: PHACOEMULSIFICATION COMBINED WITH DEXAMETHASONE INTRAVITREAL IMPLANT COMPARED WITH STANDARD PHACOEMULSIFICATION 135
Flying spot PRK: curvatura costante vs variazione costante di curvatura 134
Optical coherence tomography angiography in diabetic patients without diabetic retinopathy 134
Association of Neuroretinal Thinning and Microvascular Changes with Hypertension in an Older Population in Southern Italy 132
Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab. 130
HEMORRHAGIC MACULAR INFARCTION AFTER INTRAVITREAL BEVACIZUMAB FOR CENTRAL RETTINAL VEIN OCCLUSION 129
Microperimetric Biofeedback Training after Successful Inverted Flap Technique for Large Macular Hole 127
Anterior segment time domain optical coherence tomography 126
Comparison of perioperative parameters in one-handed rotational phacoemulsification versus conventional phacoemulsification and femtosecond laser-assisted cataract surgery 126
Combined surgical ablation and intravitreal triamcinolone acetonide for retinal angiomatous proliferation 125
Fundus autofluorescence, optical coherence tomography and visual acuity in adult-onset foveomacular dystrophy 124
PHOTODYNAMIC THERAPY WITH VERTEPORFIN FOR RETINAL ANGIOMATOUS PROLIFERATION 124
Diathermy of leacking sclerotomies after 23-gauge transconjunctival pars plana vitrectomy: a prospective study 123
Management of macular oedema in diabetic patients undergoing cataract surgery 123
Mid-term safety and effectiveness of intravitreal dexamethasone implant to treat persistent cystoid macular edema in vitrectomized eyes for bacterial endophthalmitis 119
Bromfenac eyedrops in the treatment of diabetic macular edema: a pilot study 117
Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study 116
Aflibercept in the treatment of diabetic macular edema: A review and consensus paper 116
FUNCTIONAL AND ANATOMICAL OUTCOMES AFTER SHORT-TERM HEAVY SILICONE OIL ENDOTAMPONADE FOR INFERIOR RHEGMATOGENOUS RETINAL REDETACHMENT: A Pilot Study 115
Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration 115
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration 115
Homocysteine and risk of age-related macular degeneration: a systematic review and meta-analysis 113
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD 110
Comparison of Anterior Segment Time Domain Optical Coherence Tomography and High Frequency Ultrasound Biomicroscopy for Anterior Segment 110
null 110
Anterior chamber bleeding due to intravitreal dexamethasone implant sclerotomy without vitreous hemorrhage 110
Intravitreal Injections in Arc Sterile Setting: Safety Profile after More Than 10,000 Treatments 108
Surgical Management of Complications after Dexamethasone Implant 108
Topography-driven excimer laser for the retreatment of decentralized myopic photorefractive keratectomy. 108
Abnormal protein redox status and impairment of antioxidant defense in lens and vitreous of diabetic subjects 108
Biofeedback Training after Successful Inverted Internal Limiting Membrane (ILM)-Flap Technique for High Myopic Macular Hole 107
Long-Term Impact of Diabetic Retinopathy on Response to Anti-VEGF Treatment in Neovascular AMD 107
Evaluation of the Efficacy of Ozonated Oil in Liposomes as an Adjuvant in Intravitreal Injection Prophylaxis: OPERA Study 106
Spectral-domain optical coherence tomography and fluorescein angiography features of cystoid macular edema with serous retinal detachment secondary to intracameral cefuroxime administration 106
ALTERAZIONI OSSIDATIVE DEI LIPIDI E DELLE PROTEINE NEL VITREO E NEL CRISTALLINO DI SOGGETTI DIABETICO: RELAZIONE CON I LIVELLI DI GLUTATIONE 104
In vitro antimicrobial activity of a new ophthalmic solution containing povidone-iodine 0.6% (IODIM® ) 104
IN VIVO EVIDENCE OF HYPOTROPHIC CILIARY BODY IN OCULAR ISCHEMIC SYNDROME BY ULTRASOUND BIOMICRISCOPY 103
Management of intraoperative complications during scleral buckling surgery 103
Intravitreal Therapy for Diabetic Macular Edema: An Update 103
Gentle endodiathermy of retinal vessels to mark paravascular posterior retinal breaks in highly myopic eyes 102
Perfluorocarbon liquid-assisted inverted inner limiting membrane-flap for large macular hole after recurrent rhegmatogenous retinal detachment 101
Microvascular changes in the recurrent cystoid macular edema secondary to posterior noninfectious uveitis on optical coherence tomography angiography 100
Topography-driven photorefractive keratectomy (PRK): results of Corneal Interactive Programmed Topographic Ablation (CIPTA) software 100
Incidence and Risk Factors for Tractional Macular Detachment after Anti-Vascular Endothelial Growth Factor Agent Pretreatment before Vitrectomy for Complicated Proliferative Diabetic Retinopathy 100
Neurovascular retinal impairment in early-treated adults with phenylketonuria 99
Detection of serum uric acid in primary open angle glaucoma: A pilot study 99
Anxiety and depression prevalence rates in age-related macular degeneration 98
Micropulse Laser versus Eplerenone for Chronic Central Serous Chorioretinopathy: A 12-Month Comparison 97
Comparative Study on Anti-VEGF in Wet Age-Related Macular Degeneration in the Setting Based on Lean Methodology from the Bari Intravitreal Injection Registry (BIVIR) 97
Evaluation of demarcation line after epithelium-off iontophoresis corneal collagen cross-linking for progressive keratoconus 97
IDENTIFICAZIONE PERSONALE MEDIANTE ANALISI MORFOMETRICA DELLA RETINA 96
null 96
Red cell distribution width (RDW) and complete blood cell count-derived measures in non-arteritic anterior ischemic optic neuropathy 96
Mean Platelet Volume, Red Cell Distribution Width, and Complete Blood Cell Count Indices in Retinal Vein Occlusions 95
Hemorrhagic Macular Infarction After Intravitreal Bevacizumab for Central Retinal Vein Occlusion. 94
Liposomal Ozonated Oil Ensures a Further Reduction in the Microbial Load Before Intravitreal Injection: the "OPERA" Study 94
Analysis of Choriocapillaris Reperfusion Topography Following Faricimab Treatment for Neovascular Age-Related Macular Degeneration in Therapy-Naïve Patients 93
Effect of Pro Re Nata Regimen with Anti-VEGF on Type 3 Macular Neovascularization: Long-Term Outcomes 91
Totale 13.981
Categoria #
all - tutte 100.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.017 0 0 24 40 34 118 30 60 84 109 201 317
2022/20231.644 255 251 71 141 162 200 63 149 234 20 46 52
2023/2024730 44 115 48 68 50 203 17 21 15 31 17 101
2024/20253.776 112 30 252 161 85 352 390 357 194 245 491 1.107
2025/202610.001 1.248 352 1.172 1.087 1.124 558 854 346 1.073 985 289 913
2026/20271.160 303 438 419 0 0 0 0 0 0 0 0 0
Totale 22.809